Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Retrospective and Cross-sectional Study to Evaluate Neurodevelopmental Status in Pediatric Subjects With Severe Mucopolysaccharidosis Type II (Hunter Syndrome)

NCT03529786 is registered in ClinicalTrials.gov with REGENXBIO Inc. as lead sponsor.

NCT NCT03529786
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03529786 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Retrospective and Cross-sectional Study to Evaluate Neurodevelopmental Status in Pediatric Subjects With Severe Mucopolysaccharidosis Type II (Hunter Syndrome)
Lead sponsor
REGENXBIO Inc.
Phase
Observational
Overall status
Completed
Start date
September 27, 2017
Completion date
March 22, 2022
Enrollment
36 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

mucopolysaccharidosis ii